Filing Details
- Accession Number:
- 0001179110-17-001924
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-07 18:20:56
- Reporting Period:
- 2017-02-03
- Filing Date:
- 2017-02-07
- Accepted Time:
- 2017-02-07 18:20:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1113481 | Medicines Co | MDCO | Pharmaceutical Preparations (2834) | 043324394 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1427141 | Bernard William O'connor | 8 Sylvan Way Parsippany NJ 07054 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-02-03 | 10,833 | $22.04 | 30,935 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-02-03 | 10,833 | $45.00 | 20,102 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-02-07 | 15,000 | $28.60 | 35,102 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-02-07 | 12,100 | $46.98 | 23,002 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-02-07 | 2,900 | $47.45 | 20,102 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right-to-buy) | Disposition | 2017-02-03 | 10,833 | $0.00 | 10,833 | $22.04 |
| Common Stock | Stock Option (right-to-buy) | Disposition | 2017-02-07 | 15,000 | $0.00 | 15,000 | $28.60 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-02-24 | No | 4 | M | Direct | |
| 0 | 2017-02-16 | No | 4 | M | Direct |
Footnotes
- Sales were effected pursuant to a Rule 10b5-1 program adopted by the reporting person.
- Represents the weighted average sales price of the shares sold ranging from a low of $46.35 to a high of $47.34 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- Represents the weighted average sales price of the shares sold ranging from a low of $47.35 to a high of $47.67 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- This option vested in forty-eight equal monthly installments beginning March 24, 2012.
- This option vested in forty-eight equal monthly installments beginning March 16, 2007.
- Not applicable.
Billionaire Hedge Funds
